Cited 131 times in
Decreased circulating C3 levels and mesangial C3 deposition predict renal outcome in patients with IgA nephropathy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 도화미 | - |
dc.contributor.author | 정현주 | - |
dc.contributor.author | 박정탁 | - |
dc.contributor.author | 최규헌 | - |
dc.contributor.author | 한승혁 | - |
dc.contributor.author | 오형중 | - |
dc.contributor.author | 유동은 | - |
dc.contributor.author | 강신욱 | - |
dc.contributor.author | 유태현 | - |
dc.contributor.author | 구향모 | - |
dc.contributor.author | 이미정 | - |
dc.contributor.author | 김승준 | - |
dc.contributor.author | 임범진 | - |
dc.date.accessioned | 2014-12-19T17:35:39Z | - |
dc.date.available | 2014-12-19T17:35:39Z | - |
dc.date.issued | 2012 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/91702 | - |
dc.description.abstract | BACKGROUND AND AIMS: Mesangial C3 deposition is frequently observed in patients with IgA nephropathy (IgAN). However, the role of complement in the pathogenesis or progression of IgAN is uncertain. In this observational cohort study, we aimed to identify the clinical implications of circulating C3 levels and mesangial C3 deposition and to investigate their utility as predictors of renal outcomes in patients with IgAN. METHODS: A total of 343 patients with biopsy-proven IgAN were enrolled between January 2000 and December 2008. Decreased serum C3 level (hypoC3) was defined as C3 <90 mg/dl. The study endpoint was end-stage renal disease (ESRD) and a doubling of the baseline serum creatinine (D-SCr). RESULTS: Of the patients, there were 66 patients (19.2%) with hypoC3. During a mean follow-up of 53.7 months, ESRD occurred in 5 patients (7.6%) with hypoC3 compared with 9 patients (3.2%) with normal C3 levels (P = 0.11). However, 12 patients (18.2%) with hypoC3 reached D-SCr compared with 17 patients (6.1%) with normal C3 levels [Hazard ratio (HR), 3.59; 95% confidence interval (CI), 1.33-10.36; P = 0.018]. In a multivariable model in which serum C3 levels were treated as a continuous variable, hypoC3 significantly predicted renal outcome of D-SCr (per 1 mg/dl increase of C3; HR, 0.95; 95% CI, 0.92-0.99; P = 0.011). The risk of reaching renal outcome was significantly higher in patients with mesangial C3 deposition 2+ to 3+ than in patients without deposition (HR 9.37; 95% CI, 1.10-80.26; P = 0.04). CONCLUSIONS: This study showed that hypoC3 and mesangial C3 deposition were independent risk factors for progression, suggesting that complement activation may play a pathogenic role in patients with IgAN. | - |
dc.description.statementOfResponsibility | open | - |
dc.format | application/pdf | - |
dc.relation.isPartOf | PLOS ONE | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Adult | - |
dc.subject.MESH | Biopsy | - |
dc.subject.MESH | Cohort Studies | - |
dc.subject.MESH | Complement C3/immunology | - |
dc.subject.MESH | Complement C3/metabolism* | - |
dc.subject.MESH | Creatinine/blood | - |
dc.subject.MESH | Disease Progression | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Glomerular Filtration Rate | - |
dc.subject.MESH | Glomerular Mesangium/immunology | - |
dc.subject.MESH | Glomerular Mesangium/pathology* | - |
dc.subject.MESH | Glomerulonephritis, IGA/etiology* | - |
dc.subject.MESH | Glomerulonephritis, IGA/mortality | - |
dc.subject.MESH | Glomerulonephritis, IGA/pathology* | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Prognosis | - |
dc.subject.MESH | ROC Curve | - |
dc.subject.MESH | Risk Factors | - |
dc.subject.MESH | Young Adult | - |
dc.title | Decreased circulating C3 levels and mesangial C3 deposition predict renal outcome in patients with IgA nephropathy | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Pathology (병리학) | - |
dc.contributor.googleauthor | Seung Jun Kim | - |
dc.contributor.googleauthor | Hyang Mo Koo | - |
dc.contributor.googleauthor | Beom Jin Lim | - |
dc.contributor.googleauthor | Hyung Jung Oh | - |
dc.contributor.googleauthor | Dong Eun Yoo | - |
dc.contributor.googleauthor | Dong Ho Shin | - |
dc.contributor.googleauthor | Mi Jung Lee | - |
dc.contributor.googleauthor | Fa Mee Doh | - |
dc.contributor.googleauthor | Jung Tak Park | - |
dc.contributor.googleauthor | Tae-Hyun Yoo | - |
dc.contributor.googleauthor | Shin-Wook Kang | - |
dc.contributor.googleauthor | Kyu Hun Choi | - |
dc.contributor.googleauthor | Hyeon Joo Jeong | - |
dc.contributor.googleauthor | Seung Hyeok Han | - |
dc.identifier.doi | 10.1371/journal.pone.0040495 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A01315 | - |
dc.contributor.localId | A03771 | - |
dc.contributor.localId | A01654 | - |
dc.contributor.localId | A04043 | - |
dc.contributor.localId | A02097 | - |
dc.contributor.localId | A04304 | - |
dc.contributor.localId | A02417 | - |
dc.contributor.localId | A02461 | - |
dc.contributor.localId | A00053 | - |
dc.contributor.localId | A02526 | - |
dc.contributor.localId | A00203 | - |
dc.contributor.localId | A03363 | - |
dc.contributor.localId | A00659 | - |
dc.contributor.localId | A02773 | - |
dc.relation.journalcode | J02540 | - |
dc.identifier.eissn | 1932-6203 | - |
dc.identifier.pmid | 22792353 | - |
dc.subject.keyword | Adult | - |
dc.subject.keyword | Biopsy | - |
dc.subject.keyword | Cohort Studies | - |
dc.subject.keyword | Complement C3/immunology | - |
dc.subject.keyword | Complement C3/metabolism* | - |
dc.subject.keyword | Creatinine/blood | - |
dc.subject.keyword | Disease Progression | - |
dc.subject.keyword | Female | - |
dc.subject.keyword | Glomerular Filtration Rate | - |
dc.subject.keyword | Glomerular Mesangium/immunology | - |
dc.subject.keyword | Glomerular Mesangium/pathology* | - |
dc.subject.keyword | Glomerulonephritis, IGA/etiology* | - |
dc.subject.keyword | Glomerulonephritis, IGA/mortality | - |
dc.subject.keyword | Glomerulonephritis, IGA/pathology* | - |
dc.subject.keyword | Humans | - |
dc.subject.keyword | Male | - |
dc.subject.keyword | Middle Aged | - |
dc.subject.keyword | Prognosis | - |
dc.subject.keyword | ROC Curve | - |
dc.subject.keyword | Risk Factors | - |
dc.subject.keyword | Young Adult | - |
dc.contributor.alternativeName | Doh, Fa Mee | - |
dc.contributor.alternativeName | Jeong, Hyeon Joo | - |
dc.contributor.alternativeName | Park, Jung Tak | - |
dc.contributor.alternativeName | Choi, Kyu Hun | - |
dc.contributor.alternativeName | Shin, Dong Ho | - |
dc.contributor.alternativeName | Han, Seung Hyeok | - |
dc.contributor.alternativeName | Oh, Hyung Jung | - |
dc.contributor.alternativeName | Yoo, Dong Eun | - |
dc.contributor.alternativeName | Kang, Shin Wook | - |
dc.contributor.alternativeName | Yoo, Tae Hyun | - |
dc.contributor.alternativeName | Koo, Hyang Mo | - |
dc.contributor.alternativeName | Lee, Mi Jung | - |
dc.contributor.alternativeName | Kim, Seung Jun | - |
dc.contributor.alternativeName | Lim, Beom Jin | - |
dc.contributor.affiliatedAuthor | Doh, Fa Mee | - |
dc.contributor.affiliatedAuthor | Jeong, Hyeon Joo | - |
dc.contributor.affiliatedAuthor | Park, Jung Tak | - |
dc.contributor.affiliatedAuthor | Choi, Kyu Hun | - |
dc.contributor.affiliatedAuthor | Shin, Dong Ho | - |
dc.contributor.affiliatedAuthor | Han, Seung Hyeok | - |
dc.contributor.affiliatedAuthor | Oh, Hyung Jung | - |
dc.contributor.affiliatedAuthor | Yoo, Dong Eun | - |
dc.contributor.affiliatedAuthor | Kang, Shin Wook | - |
dc.contributor.affiliatedAuthor | Yoo, Tae Hyun | - |
dc.contributor.affiliatedAuthor | Koo, Hyang Mo | - |
dc.contributor.affiliatedAuthor | Lim, Beom Jin | - |
dc.contributor.affiliatedAuthor | Kim, Seung Jun | - |
dc.contributor.affiliatedAuthor | Lee, Mi Jung | - |
dc.citation.volume | 7 | - |
dc.citation.number | 7 | - |
dc.citation.startPage | e40495 | - |
dc.identifier.bibliographicCitation | PLOS ONE, Vol.7(7) : e40495, 2012 | - |
dc.identifier.rimsid | 29567 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.